Selective Inhibitors of Butyrylcholinesterase: A Valid Alternative for Therapy of Alzheimer's Disease?

ISSN： 1170-229X

Source： Drugs & Aging, Vol.18, Iss.12, 2001-12, pp. : 891-898

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is there a Future for Cyclo-Oxygenase Inhibitors in Alzheimer's Disease?

By Ho Lap Qin Weiping Stetka Breton S. Pasinetti Giulio M.

CNS Drugs, Vol. 20, Iss. 2, 2006-01 ,pp. : 85-98

Adis International

Access to resources Recommend Favorite

Angiogenesis inhibitors may be effective in Alzheimer's disease?

Inpharma, Vol. 1, Iss. 1375, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Do Cholinesterase Inhibitors Have Disease-Modifying Effects in Alzheimer's Disease?

By Giacobini E.

CNS Drugs, Vol. 15, Iss. 2, 2001-01 ,pp. : 85-91

Adis International

Access to resources Recommend Favorite

Carotid Intima-Media Thickness: A Predictor of Response to Cholinesterase Inhibitors in Alzheimer's Disease?

By Saleh DrChristian

CNS Drugs, Vol. 24, Iss. 9, 2010-09 ,pp. : 801-803

Adis International

Access to resources Recommend Favorite

Donepezil - benefits extend to advanced Alzheimer's disease?

Inpharma, Vol. 1, Iss. 1236, 2000-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite